• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

炎症和激素在伴有恶病质的转移性癌症患者中的预后作用。

The prognostic role of inflammation and hormones in patients with metastatic cancer with cachexia.

作者信息

Bilir Cemil, Engin Huseyin, Can Murat, Temi Yasemin Bakkal, Demirtas Derya

机构信息

Division of Medical Oncology, Department of Internal Medicine, Bulent Ecevit University School of Medicine, Sultan Orhan Mh 1145 sk No:14, Zonguldak, Turkiye,

出版信息

Med Oncol. 2015 Mar;32(3):56. doi: 10.1007/s12032-015-0497-y. Epub 2015 Feb 1.

DOI:10.1007/s12032-015-0497-y
PMID:25638467
Abstract

We wanted to investigate the possible etiologic factors of cachexia. Forty-six patients diagnosed with cancer cachexia and 34 healthy controls were included in the study. Serum total testosterone, free testosterone, interleukin 1 (IL) alpha and beta, IL6, tumor necrosis factor (TNF) alpha, orexin, galanin, neuropeptide Y, tumor necrosis factor-like weak inducer of apoptosis and tumor necrosis factor receptor-associated factor 6, and C-reactive protein (CRP) levels were investigated. There were 36 male and 10 female patients in the cachexia group, and 24 male and 10 female patients in the control group. Median overall survival (OS) of the cachexia group after the diagnosis of cachexia was 8 (1-25) months. There were statistically significant relationships between OS and BMI, serum CRP, TRAF-6, albumin, and LDH levels in the cachexia group. In addition to cachexia, serum CRP, testosterone, and TNF alpha levels were statistically significantly correlated with OS in refractory cachexia. TRAF-6 levels was significantly correlated with type of cancer (P = 0.02). Although cachexia presents with a multifactorial ethio-pathogenesis, few of them affect the OS. Our novel results were that serum CRP, albumin, LDH, and TRAF-6 levels have a higher association with OS in patients with cancer cachexia compared to the many other parameters. An ongoing cachexia also called refractory cachexia is a recent definition. This end-stage term of cancer duration may be predicted by decreasing serum testosterone and increasing serum TNF alpha levels, as well as serum CRP levels.

摘要

我们想要研究恶病质可能的病因。本研究纳入了46例被诊断为癌症恶病质的患者和34名健康对照者。检测了血清总睾酮、游离睾酮、白细胞介素1(IL)α和β、IL6、肿瘤坏死因子(TNF)α、食欲素、甘丙肽、神经肽Y、肿瘤坏死因子样凋亡弱诱导剂、肿瘤坏死因子受体相关因子6以及C反应蛋白(CRP)水平。恶病质组有36例男性和10例女性患者,对照组有24例男性和10例女性患者。恶病质组在诊断恶病质后的中位总生存期(OS)为8(1 - 25)个月。恶病质组的OS与BMI、血清CRP、TRAF - 6、白蛋白和乳酸脱氢酶(LDH)水平之间存在统计学显著相关性。除恶病质外难治性恶病质患者的血清CRP、睾酮和TNFα水平与OS在统计学上显著相关。TRAF - 6水平与癌症类型显著相关(P = 0.02)。尽管恶病质呈现多因素病因发病机制,但其中很少因素影响OS。我们的新结果是,与许多其他参数相比,癌症恶病质患者的血清CRP、白蛋白、LDH和TRAF - 6水平与OS的关联更高。一种持续存在的恶病质也称为难治性恶病质是最近的定义。癌症病程的这个终末期可能通过血清睾酮降低、血清TNFα水平升高以及血清CRP水平升高来预测。

相似文献

1
The prognostic role of inflammation and hormones in patients with metastatic cancer with cachexia.炎症和激素在伴有恶病质的转移性癌症患者中的预后作用。
Med Oncol. 2015 Mar;32(3):56. doi: 10.1007/s12032-015-0497-y. Epub 2015 Feb 1.
2
The correlation between a chronic inflammatory marker Tartrate-resistant acid phosphatase 5a with cancer cachexia.慢性炎症标志物抗酒石酸酸性磷酸酶5a与癌症恶病质之间的相关性。
J BUON. 2015 Jan-Feb;20(1):325-31.
3
Low testosterone levels and increased inflammatory markers in patients with cancer and relationship with cachexia.癌症患者的低睾酮水平和炎症标志物增加与恶病质的关系。
J Clin Endocrinol Metab. 2012 May;97(5):E700-9. doi: 10.1210/jc.2011-2387. Epub 2012 Mar 14.
4
Impact of TNF-alpha and IL-6 levels on development of cachexia in newly diagnosed NSCLC patients.肿瘤坏死因子-α和白细胞介素-6水平对新诊断非小细胞肺癌患者恶病质发生发展的影响。
Am J Clin Oncol. 2006 Aug;29(4):328-35. doi: 10.1097/01.coc.0000221300.72657.e0.
5
Associations among hypogonadism, C-reactive protein, symptom burden, and survival in male cancer patients with cachexia: a preliminary report.性腺功能减退症、C 反应蛋白、症状负担与癌症恶病质男性患者生存的相关性:初步报告。
J Pain Symptom Manage. 2010 Jun;39(6):1016-24. doi: 10.1016/j.jpainsymman.2009.09.021. Epub 2010 May 10.
6
Association between hypogonadism, symptom burden, and survival in male patients with advanced cancer.性腺功能减退症与晚期癌症男性患者的症状负担和生存的关系。
Cancer. 2014 May 15;120(10):1586-93. doi: 10.1002/cncr.28619. Epub 2014 Feb 27.
7
[Plasma concentration of leptin, neuropeptide Y and tumor necrosis factor alpha in patients with cancers, before and after radio- and chemotherapy].[癌症患者放化疗前后瘦素、神经肽Y及肿瘤坏死因子α的血浆浓度]
Pol Arch Med Wewn. 2001 Aug;106(2):657-68.
8
The relationship between LDH and GLIM criteria for cancer cachexia: Systematic review and meta-analysis.LDH 与癌症恶病质 GLIM 标准的关系:系统评价和荟萃分析。
Crit Rev Oncol Hematol. 2024 Jul;199:104378. doi: 10.1016/j.critrevonc.2024.104378. Epub 2024 May 14.
9
Systemic inflammation in patients with COPD and pulmonary hypertension.慢性阻塞性肺疾病(COPD)合并肺动脉高压患者的全身炎症
Chest. 2006 Aug;130(2):326-33. doi: 10.1378/chest.130.2.326.
10
Weight loss and resting energy expenditure in male patients with newly diagnosed esophageal cancer.男性新发食管癌患者的体重减轻和静息能量消耗。
Nutrition. 2013 Nov-Dec;29(11-12):1310-4. doi: 10.1016/j.nut.2013.04.010. Epub 2013 Sep 4.

引用本文的文献

1
Comprehensive evaluation of serum hepatic proteins in predicting prognosis among cancer patients with cachexia: an observational cohort study.综合性评估血清肝蛋白在预测癌症恶病质患者预后中的作用:一项观察性队列研究。
BMC Cancer. 2024 Mar 4;24(1):293. doi: 10.1186/s12885-024-12056-5.
2
Cancer cachexia: biomarkers and the influence of age.癌症恶病质:生物标志物和年龄的影响。
Mol Oncol. 2024 Sep;18(9):2070-2086. doi: 10.1002/1878-0261.13590. Epub 2024 Feb 27.
3
The role of myokines in cancer: crosstalk between skeletal muscle and tumor.

本文引用的文献

1
Patients' rationale for declining participation in a cancer-associated weight loss study.患者拒绝参与癌症相关体重减轻研究的理由。
J Cachexia Sarcopenia Muscle. 2014 Jun;5(2):121-5. doi: 10.1007/s13539-014-0128-z. Epub 2014 Mar 13.
2
Functional expression of TWEAK and the receptor Fn14 in human malignant ovarian tumors: possible implication for ovarian tumor intervention.TWEAK 和受体 Fn14 在人恶性卵巢肿瘤中的功能表达:对卵巢肿瘤干预的可能意义。
PLoS One. 2013;8(3):e57436. doi: 10.1371/journal.pone.0057436. Epub 2013 Mar 4.
3
Diagnostic criteria of cancer cachexia: relation to quality of life, exercise capacity and survival in unselected palliative care patients.
肌肉因子在癌症中的作用:骨骼肌与肿瘤的相互作用。
BMB Rep. 2023 Jul;56(7):365-373. doi: 10.5483/BMBRep.2023-0064.
4
S100A8, S100A9 and S100A8/A9 heterodimer as novel cachexigenic factors for pancreatic cancer-induced cachexia.S100A8、S100A9 和 S100A8/A9 异二聚体作为胰腺癌诱导恶病质的新型恶病质因子。
BMC Cancer. 2023 Jun 6;23(1):513. doi: 10.1186/s12885-023-11009-8.
5
A novel orthotopic mouse model replicates human lung cancer cachexia.一种新型的原位小鼠模型可复制人类肺癌恶病质。
J Cachexia Sarcopenia Muscle. 2023 Jun;14(3):1410-1423. doi: 10.1002/jcsm.13222. Epub 2023 Apr 6.
6
Exercise as a therapy for cancer-induced muscle wasting.运动作为癌症引起的肌肉萎缩的一种治疗方法。
Sports Med Health Sci. 2020 Dec 3;2(4):186-194. doi: 10.1016/j.smhs.2020.11.004. eCollection 2020 Dec.
7
MicroRNAs: Novel players in the diagnosis and treatment of cancer cachexia (Review).微小RNA:癌症恶病质诊断与治疗中的新角色(综述)
Exp Ther Med. 2022 May 16;24(1):446. doi: 10.3892/etm.2022.11373. eCollection 2022 Jul.
8
Cancer- and cardiac-induced cachexia: same fate through different inflammatory mediators?癌症和心脏引起的恶病质:不同炎症介质导致相同的命运?
Inflamm Res. 2022 Aug;71(7-8):771-783. doi: 10.1007/s00011-022-01586-y. Epub 2022 Jun 9.
9
Tumor cell anabolism and host tissue catabolism-energetic inefficiency during cancer cachexia.肿瘤细胞合成代谢与宿主组织分解代谢-癌症恶病质期间的能量效率低下。
Exp Biol Med (Maywood). 2022 May;247(9):713-733. doi: 10.1177/15353702221087962. Epub 2022 May 6.
10
Exercise medicine for cancer cachexia: targeted exercise to counteract mechanisms and treatment side effects.运动医学与癌症恶病质:靶向运动以对抗机制和治疗副作用。
J Cancer Res Clin Oncol. 2022 Jun;148(6):1389-1406. doi: 10.1007/s00432-022-03927-0. Epub 2022 Jan 27.
癌症恶病质的诊断标准:与未经选择的姑息治疗患者的生活质量、运动能力和生存的关系。
Support Care Cancer. 2013 Jun;21(6):1569-77. doi: 10.1007/s00520-012-1697-z. Epub 2013 Jan 13.
4
Expression of TRAF6 and ubiquitin mRNA in skeletal muscle of gastric cancer patients.胃癌患者骨骼肌中 TRAF6 和泛素 mRNA 的表达。
J Exp Clin Cancer Res. 2012 Sep 26;31(1):81. doi: 10.1186/1756-9966-31-81.
5
Experimental study of the effect of IL-6 on cancer cachexia.白细胞介素-6对癌症恶病质影响的实验研究
Oncol Rep. 1997 Sep-Oct;4(5):921-6. doi: 10.3892/or.4.5.921.
6
Targeted ablation of TRAF6 inhibits skeletal muscle wasting in mice.靶向消融 TRAF6 抑制小鼠骨骼肌萎缩。
J Cell Biol. 2010 Dec 27;191(7):1395-411. doi: 10.1083/jcb.201006098.
7
Pretreatment serum albumin as a predictor of cancer survival: a systematic review of the epidemiological literature.预处理血清白蛋白作为癌症生存预测指标的系统评价:流行病学文献综述。
Nutr J. 2010 Dec 22;9:69. doi: 10.1186/1475-2891-9-69.
8
The TRAF2 and TRAF6 expression in myomas and myometrium of women in reproduction and perimenopausal age.育龄期和围绝经期女性子宫肌瘤及子宫肌层中TRAF2和TRAF6的表达
Folia Histochem Cytobiol. 2010 Sep 30;48(3):407-16. doi: 10.2478/v10042-010-0039-6.
9
The TWEAK-Fn14 cytokine-receptor axis: discovery, biology and therapeutic targeting.TWEAK-Fn14细胞因子-受体轴:发现、生物学特性及治疗靶点
Nat Rev Drug Discov. 2008 May;7(5):411-25. doi: 10.1038/nrd2488.
10
Biomarkers for cancer cachexia: is there also a genetic component to cachexia?癌症恶病质的生物标志物:恶病质是否也存在遗传因素?
Support Care Cancer. 2008 Mar;16(3):229-34. doi: 10.1007/s00520-007-0367-z. Epub 2007 Dec 11.